Virnext was pleased to attend the BioFIT Event 2024.

The event provided a great opportunity to present our expertise in emerging and re-emerging respiratory viruses, as well as our continuum of in vitro and in vivo preclinical models of infection. We had valuable discussions with many professionals about how we can support their research and development projects.

During the event, we highlighted our key services:

• Production of high-quality, characterized viruses and viral vaccine antigens using egg-based and cell-based systems
• Evaluation of therapeutic and prophylactic candidates in various preclinical models of respiratory virus infection
• Virology services for the analysis and characterization of complex biological and clinical samples